S
0.100
0.00 (-4.76%)
| Previous Close | 0.105 |
| Open | 0.100 |
| Volume | 546,200 |
| Avg. Volume (3M) | 870,431 |
| Market Cap | 48,404,500 |
| Price / Sales | 0.660 |
| Price / Book | 0.710 |
| 52 Weeks Range |
| Profit Margin | -11.07% |
| Operating Margin (TTM) | -17.71% |
| Diluted EPS (TTM) | -0.020 |
| Quarterly Revenue Growth (YOY) | -75.70% |
| Total Debt/Equity (MRQ) | 7.54% |
| Current Ratio (MRQ) | 2.25 |
| Operating Cash Flow (TTM) | -1.90 M |
| Levered Free Cash Flow (TTM) | 4.26 M |
| Return on Assets (TTM) | -5.21% |
| Return on Equity (TTM) | -13.15% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Scientific & Technical Instruments (MY) | Mixed | Mixed |
| Scientific & Technical Instruments (Global) | Bearish | Mixed | |
| Stock | SOLUTN | - | - |
AIStockmoo Score
-0.1
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -3.0 |
| Average | -0.13 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| SOLUTN | 48 M | - | - | 0.710 |
| CREST | 160 M | 2.05% | 6.17 | 1.52 |
|
Solution Group Bhd is an investment holding company. Its operating segments include Engineering Equipment, Industrial Automation, Metal Fabrication and Assembly, Green and Renewable Energy, Biopharmaceuticals, Investment, and Others. Geographically, the company serves Malaysian as well as Overseas customers. It has three manufacturing sites, two located in Selangor and one in Kuala Lumpur. |
|
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Investment Style | Small Value |
| % Held by Insiders | 58.51% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 01 Jul 2025 | Announcement | INTERNATIONAL EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SOLUTION BIOLOGICS SDN BHD ("SOLBIO"), A WHOLLY-OWNED SUBSIDIARY OF SOLUTION GROUP BERHAD ("SGB" or "the Company") AND XIAMEN INNOVAX BIOTECH CO., LTD ("INNOVAX") FOR THE SUPPLY OF THE RECOMBINANT HUMAN PAPILLOMAVIRUS BIVALENT VACCINE. |
| 29 May 2025 | Announcement | General Meetings: Outcome of Meeting |
| 29 May 2025 | Announcement | Quarterly rpt on consolidated results for the financial period ended 31/03/2025 |
| 30 Apr 2025 | Announcement | Annual Report & CG Report - 2024 |
| 30 Apr 2025 | Announcement | Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - DATUK LIM NYUK SANG @ FREDDY LIM |
| 30 Apr 2025 | Announcement | STATEMENT TO SHAREHOLDERS IN RELATION TO THE PROPOSED RENEWAL OF SHARE BUY-BACK AUTHORITY |
| 29 Apr 2025 | Announcement | General Meetings: Notice of Meeting |
| 21 Apr 2025 | Announcement | SOLUTION GROUP BERHAD ("THE COMPANY") - Proposed Renewal of Share Buy-Back Authority |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 10 Mar 2022 | 24 Feb 2022 | 23 Mar 2022 | 0.02 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2022 | 0.020 | 1 | 6.56 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |